The cost effectiveness of vaccinating against lyme disease
Download
1 / 4

The Cost Effectiveness of Vaccinating against Lyme Disease - PowerPoint PPT Presentation


  • 57 Views
  • Uploaded on

The Cost Effectiveness of Vaccinating against Lyme Disease. Martin I. Meltzer, David T. Dennis, and Kathleen A. Orloski Centers for Disease Control and Prevention, Atlanta, Georgia, USA http://www.cdc.gov/ncidod/EID/vol5no3/meltzer.htm#table 2. Abstract.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' The Cost Effectiveness of Vaccinating against Lyme Disease' - rosina


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
The cost effectiveness of vaccinating against lyme disease

The Cost Effectiveness of Vaccinating against Lyme Disease

Martin I. Meltzer, David T. Dennis, and Kathleen A. Orloski

Centers for Disease Control and Prevention, Atlanta, Georgia, USA

http://www.cdc.gov/ncidod/EID/vol5no3/meltzer.htm#table 2


Abstract
Abstract

  • To determine the cost effectiveness of vaccinating against Lyme disease, we used a decision tree to examine the impact on society of six key components.

  • The main measure of outcome was the cost per case averted. Assuming a 0.80 probability of diagnosing and treating early Lyme disease, a 0.005 probability of contracting Lyme disease, and a vaccination cost of $50 per year, the mean cost of vaccination per case averted was $4,466.

  • When we increased the probability of contracting Lyme disease to 0.03 and the cost of vaccination to $100 per year, the mean net savings per case averted was $3,377.

  • Since few communities have average annual incidences of Lyme disease >0.005, economic benefits will be greatest when vaccination is used on the basis of individual risk, specifically, in persons whose probability of contracting Lyme disease is >0.01.



ad